---
title: "Machine Learning-Guided microfluidic optimization of clinically inspired liposomes for nanomedicine applications"
collection: publications
permalink: /publication/2025-11-12-IJP1
excerpt: 'This article discusses the transformative role of machine learning in optimizing liposome development, a process traditionally limited by 
its complexity, high cost, and time-intensive experimentation. By analyzing over 300 experimental conditions using a microfluidic production 
platform inspired by the formulations of Doxil® and Marqibo®, the study demonstrates how predictive models can efficiently determine key liposome 
characteristics such as particle size and polydispersity index. An open-source simulation tool was also developed to allow researchers to virtually design and test formulations, reducing the need for 
extensive laboratory work. The models were validated through independent experiments, confirming their robustness and adaptability. 
Code available [here](https://github.com/leonardoLavagna/Intelligent-Control-of-Microfluidic-Systems) with an associated app [here](https://smart-microfluidics.streamlit.app).'
date: 2025-11-12
venue: 'International Journal of Pharmaceutics'
paperurl: 'https://www.sciencedirect.com/science/article/pii/S0378517325011998'
citation: 'G. Buttitta, L. Lavagna, S. Bonacorsi, C. Barbarito, M. Moliterno, G. Saito, I. Oddone, G. Verdone, S. Raimondi, M. Panella,
"Machine Learning-Guided microfluidic optimization of clinically inspired liposomes for nanomedicine applications",
International Journal of Pharmaceutics, Vol. 686, 2025.'
---
This article discusses the transformative potential of machine learning in revolutionizing liposome development, a field that, despite its major 
impact on drug delivery, remains highly complex, resource-intensive, and dependent on extensive experimental optimization. Liposomes have
significantly improved the solubility, stability, and bioavailability of therapeutic agents, contributing to their widespread clinical use 
and a rapidly growing multi-billion-dollar market. However, the traditional formulation process requires iterative trial-and-error experiments 
to fine-tune critical parameters such as particle size and polydispersity index. To address these challenges, this study applies machine learning 
algorithms to optimize liposome production using a microfluidic platform, drawing inspiration from two clinically validated formulations—Doxil® 
and Marqibo®. More than 300 experimental conditions were systematically explored to train predictive models capable of accurately forecasting 
liposome properties and guiding formulation design. Additionally, the researchers developed an open-source simulation tool that allows scientists 
to virtually navigate formulation spaces, design optimal experiments, and perform scenario analyses without extensive lab work. All models underwent 
rigorous validation through independent wet-lab experiments, confirming their robustness, accuracy, and adaptability even under resource-limited 
conditions. Collectively, these findings demonstrate that integrating machine learning into liposome research can streamline formulation development, 
enhance reproducibility, and facilitate efficient scale-up from research to commercial production, while aligning with regulatory frameworks and 
advancing Quality by Design principles in nanomedicine.

Code available [here](https://github.com/leonardoLavagna/Intelligent-Control-of-Microfluidic-Systems) with an associated app [here](https://smart-microfluidics.streamlit.app).
